Entrez ID | Symbol | Replicates | Species | Organ | Tissue | Adj P-value | Log2FC | Malignancy |
6563 | SLC14A1 | P2T-E | Human | Esophagus | ESCC | 5.17e-27 | 1.09e+00 | 0.1177 |
6563 | SLC14A1 | P8T-E | Human | Esophagus | ESCC | 2.93e-15 | 4.81e-01 | 0.0889 |
6563 | SLC14A1 | P61T-E | Human | Esophagus | ESCC | 2.42e-03 | 1.07e-01 | 0.099 |
6563 | SLC14A1 | P76T-E | Human | Esophagus | ESCC | 4.16e-22 | 5.80e-01 | 0.1207 |
6563 | SLC14A1 | P79T-E | Human | Esophagus | ESCC | 1.47e-14 | 4.72e-01 | 0.1154 |
6563 | SLC14A1 | GSM5252126_BPH283PrGF_Via | Human | Prostate | BPH | 6.26e-23 | 1.09e+00 | -0.1771 |
6563 | SLC14A1 | GSM5252127_BPH283PrSF_Via | Human | Prostate | BPH | 3.16e-07 | 7.62e-01 | -0.1453 |
6563 | SLC14A1 | GSM5252128_BPH327PrGF_Via | Human | Prostate | BPH | 3.49e-39 | 1.28e+00 | -0.1688 |
6563 | SLC14A1 | GSM5252129_BPH327PrSF_Via | Human | Prostate | BPH | 2.09e-17 | 1.22e+00 | -0.1697 |
6563 | SLC14A1 | GSM5252130_BPH340PrGF_Via | Human | Prostate | BPH | 9.50e-58 | 2.11e+00 | -0.1972 |
6563 | SLC14A1 | GSM5252131_BPH340PrSF_Via | Human | Prostate | BPH | 3.60e-62 | 2.10e+00 | -0.2126 |
6563 | SLC14A1 | GSM5252132_BPH389PrGF | Human | Prostate | BPH | 9.31e-10 | 1.68e+00 | -0.2247 |
6563 | SLC14A1 | GSM5252133_BPH389PrSF | Human | Prostate | BPH | 1.73e-04 | 1.81e+00 | -0.2027 |
6563 | SLC14A1 | GSM5252134_BPH511PrG_Fcol_3GEX | Human | Prostate | BPH | 8.51e-20 | 1.23e+00 | -0.1433 |
6563 | SLC14A1 | GSM5252135_BPH511PrPUr_Fcol_3GEX | Human | Prostate | BPH | 1.85e-19 | 1.42e+00 | -0.1833 |
6563 | SLC14A1 | GSM5252136_BPH556PrGA1_Fcol | Human | Prostate | BPH | 7.53e-28 | 1.71e+00 | -0.23 |
6563 | SLC14A1 | GSM5252137_BPH556PrGA2_Fcol | Human | Prostate | BPH | 3.84e-20 | 2.04e+00 | -0.23 |
6563 | SLC14A1 | 047563_1562-all-cells | Human | Prostate | BPH | 6.49e-22 | 8.40e-02 | 0.0791 |
6563 | SLC14A1 | 048752_1579-all-cells | Human | Prostate | BPH | 2.52e-60 | 9.70e-01 | 0.1008 |
6563 | SLC14A1 | 052095_1628-all-cells | Human | Prostate | BPH | 9.75e-23 | 6.74e-01 | 0.1032 |
Hugo Symbol | Variant Class | Variant Classification | dbSNP RS | HGVSc | HGVSp | HGVSp Short | SWISSPROT | BIOTYPE | SIFT | PolyPhen | Tumor Sample Barcode | Tissue | Histology | Sex | Age | Stage | Therapy Types | Drugs | Outcome |
SLC14A1 | SNV | Missense_Mutation | novel | c.67T>G | p.Phe23Val | p.F23V | Q13336 | protein_coding | tolerated_low_confidence(0.26) | benign(0.359) | TCGA-B5-A1MR-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | >=65 | III/IV | Unknown | Unknown | SD |
SLC14A1 | SNV | Missense_Mutation | novel | c.648C>A | p.Phe216Leu | p.F216L | Q13336 | protein_coding | tolerated(1) | benign(0.013) | TCGA-B5-A1MR-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | >=65 | III/IV | Unknown | Unknown | SD |
SLC14A1 | SNV | Missense_Mutation | novel | c.832N>A | p.Leu278Met | p.L278M | Q13336 | protein_coding | deleterious(0.02) | probably_damaging(0.996) | TCGA-B5-A1MX-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | I/II | Hormone Therapy | megace | SD |
SLC14A1 | SNV | Missense_Mutation | novel | c.970N>T | p.Ile324Leu | p.I324L | Q13336 | protein_coding | tolerated(0.23) | benign(0.001) | TCGA-BG-A222-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | I/II | Unknown | Unknown | SD |
SLC14A1 | SNV | Missense_Mutation | | c.596N>G | p.Phe199Cys | p.F199C | Q13336 | protein_coding | deleterious(0) | possibly_damaging(0.891) | TCGA-BS-A0UV-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | III/IV | Unknown | Unknown | SD |
SLC14A1 | SNV | Missense_Mutation | novel | c.355N>A | p.Leu119Ile | p.L119I | Q13336 | protein_coding | deleterious(0) | possibly_damaging(0.814) | TCGA-DF-A2KV-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | I/II | Unknown | Unknown | SD |
SLC14A1 | SNV | Missense_Mutation | rs867037711 | c.236N>T | p.Ser79Leu | p.S79L | Q13336 | protein_coding | tolerated(0.05) | benign(0.003) | TCGA-EO-A22X-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | III/IV | Unspecific | Carboplatin | Complete Response |
SLC14A1 | SNV | Missense_Mutation | novel | c.209N>T | p.Thr70Ile | p.T70I | Q13336 | protein_coding | tolerated(0.3) | benign(0.25) | TCGA-EO-A3KX-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | >=65 | I/II | Unknown | Unknown | SD |
SLC14A1 | SNV | Missense_Mutation | | c.1224N>T | p.Met408Ile | p.M408I | Q13336 | protein_coding | tolerated(0.32) | benign(0) | TCGA-EY-A212-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | >=65 | III/IV | Unknown | Unknown | PD |
SLC14A1 | deletion | Frame_Shift_Del | novel | c.1235delA | p.Asn412IlefsTer50 | p.N412Ifs*50 | Q13336 | protein_coding | | | TCGA-E6-A2P8-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | III/IV | Unknown | Unknown | PD |